age well
Leading the conversation in hormone health and wellness
From media outlets to regional features, RegenCen is recognized as a leader in hormone health, menopause treatments, and regenerative medicine. Our founders are honored to share their expertise and help shape the conversation around vitality, aging, and science-based approaches to living well.
What the FDA’s hormone therapy update means for women: Dr. Gustav Lo explains
For more than 20 years, women were warned away from hormone replacement therapy (HRT) and left to struggle through hot flashes, sleep disruption, fatigue, and mood changes. Now, the FDA has reversed its stance on menopause hormone therapy, acknowledging what the science has shown all along. At RegenCen, we’ve offered personalized, medically guided hormone care from the beginning, long before the FDA finally caught up.
In these media interviews, Dr. Gustav Lo, Founder and Chief Medical Officer of RegenCen, explains what this historic update means for menopause treatment, why outdated fears were misleading, and how bioidentical hormone therapy can restore energy, clarity, sleep, and long-term health protection for women in perimenopause, menopause, and beyond.
Menopause has a new future, and you deserve to be part of it.
Dr. Lo comments on the FDA major Hormone therapy update
How hormone therapies can help women and the FDA update
RegenCen commercial media
Weight loss
Low testosterone, or "Low T"
Unique menopause experience
Weight management
RegenCen radio interviews
Interested in featuring us?
Contact Brooke Harris at brooke@cslcbeauty.com for all PR requests.
